Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Warfarin is not the anticoagulant of choice for malignancy-associated venous thromboembolism.

Clay TD, Craven P, Gabbay E.

Intern Med J. 2019 Jul;49(7):934. doi: 10.1111/imj.14343. No abstract available.

PMID:
31295787
2.

Go in Peace: Brain Death, Reasonable Accommodation and Jewish Mourning Rituals.

Gabbay E, Fins JJ.

J Relig Health. 2019 Jul 6. doi: 10.1007/s10943-019-00874-y. [Epub ahead of print]

PMID:
31280412
3.

Threshold of Pulmonary Hypertension Associated With Increased Mortality.

Strange G, Stewart S, Celermajer DS, Prior D, Scalia GM, Marwick TH, Gabbay E, Ilton M, Joseph M, Codde J, Playford D; NEDA Contributing Sites.

J Am Coll Cardiol. 2019 Jun 4;73(21):2660-2672. doi: 10.1016/j.jacc.2019.03.482.

PMID:
31146810
4.

Pulmonary arterial hypertension outcomes upon endothelin-1 receptor antagonist switch to macitentan.

Tynan T, Hird K, Hannon T, Gabbay E.

J Int Med Res. 2019 May;47(5):2177-2186. doi: 10.1177/0300060519840130. Epub 2019 Apr 12.

5.

Advances in screening for undiagnosed atrial fibrillation for stroke prevention and implications for patients with obstructive sleep apnoea: a literature review and research agenda.

Gahungu N, Judkins C, Gabbay E, Playford D.

Sleep Med. 2019 May;57:107-114. doi: 10.1016/j.sleep.2019.01.036. Epub 2019 Feb 11. Review.

PMID:
30954787
6.

Frequency of Ethical Issues on a Hospitalist Teaching Service at an Urban, Tertiary Care Center.

McCarthy MW, de Asua DR, Gabbay E, Christos PJ, Fins JJ.

J Hosp Med. 2019 May;14(5):290-293. doi: 10.12788/jhm.3179.

PMID:
30897052
7.

Polyarticular arthropathy and encephalopathy in a 70-year-old woman.

Lewis CS, Skiba R, Gabbay E.

BMJ Case Rep. 2018 Dec 13;11(1). pii: e227058. doi: 10.1136/bcr-2018-227058.

PMID:
30567247
8.

The National Echocardiography Database Australia (NEDA): Rationale and methodology.

Strange G, Celermajer DS, Marwick T, Prior D, Ilton M, Codde J, Scalia GM, Stewart S, Bulsara M, Gabbay E, Playford D.

Am Heart J. 2018 Oct;204:186-189. doi: 10.1016/j.ahj.2018.07.001. Epub 2018 Jul 17.

PMID:
30098706
9.

Psychiatry, Cultural Competency, and the Care of Ultra-Orthodox Jews: Achieving Secular and Theocentric Convergence Through Introspection.

Bloch AM, Gabbay E, Knowlton SF, Fins JJ.

J Relig Health. 2018 Oct;57(5):1702-1716. doi: 10.1007/s10943-018-0678-z.

PMID:
30078155
10.

Lung transplant: the Western Australian experience.

Dhillon S, McKinnon E, Wrobel J, Lavender M, Lawrence S, Gabbay E, Musk M.

Intern Med J. 2018 Nov;48(11):1337-1345. doi: 10.1111/imj.14001.

PMID:
29923278
11.

Off the Charts: <i>Medical documentation and selective redaction in the age of transparency</i>.

McCarthy MW, de Asua DR, Gabbay E, Fins JJ.

Perspect Biol Med. 2018;61(1):118-129. doi: 10.1353/pbm.2018.0031.

PMID:
29805152
12.

Outcomes of very elderly treated with dialysis for acute kidney injury
.

Gabbay E, Zangi Y, Bnayah A, Atrash J, Slotki I, Shavit L.

Clin Nephrol. 2018 Sep;90(3):185-193. doi: 10.5414/CN109385.

PMID:
29750636
13.

Inferior vena cava filters (IVCFs): a review of uses and application to international guidelines at a single Australian center; implications of venous thromboembolism associated with malignancy.

Craven P, Daly C, Oates R, Sikotra N, Clay T, Gabbay E.

Pulm Circ. 2018 Apr-Jun;8(2):2045894018776505. doi: 10.1177/2045894018776505. Epub 2018 Apr 25.

14.

Amazing and Fantastic Infection Control: The Case of Dialyzer Reuse.

Gabbay E, Meyer KB.

Am J Kidney Dis. 2017 Jun;69(6):717-719. doi: 10.1053/j.ajkd.2017.03.003. No abstract available.

PMID:
28532633
15.

The Care of the Ultra-Orthodox Jewish Patient.

Gabbay E, McCarthy MW, Fins JJ.

J Relig Health. 2017 Apr;56(2):545-560. doi: 10.1007/s10943-017-0356-6.

PMID:
28102466
16.

Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol.

Calderone A, Stevens W, Prior D, Nandurkar H, Gabbay E, Proudman SM, Williams T, Celermajer D, Sahhar J, Wong PK, Thakkar V, Dwyer N, Wrobel J, Chin W, Liew D, Staples M, Buchbinder R, Nikpour M.

BMJ Open. 2016 Dec 8;6(12):e011028. doi: 10.1136/bmjopen-2016-011028.

17.

The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.

Thakkar V, Stevens W, Prior D, Rabusa C, Sahhar J, Walker JG, Roddy J, Lester S, Rischmueller M, Zochling J, Nash P, Gabbay E, Youssef P, Proudman SM, Nikpour M.

Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):129-136. Epub 2016 May 23.

PMID:
27214686
18.

Assessing the feasibility of a web-based registry for multiple orphan lung diseases: the Australasian Registry Network for Orphan Lung Disease (ARNOLD) experience.

Casamento K, Laverty A, Wilsher M, Twiss J, Gabbay E, Glaspole I, Jaffe A; On behalf the Pulmonary Interstitial Vascular Organisational Taskforce (PIVOT) of Lung Foundation Australia.

Orphanet J Rare Dis. 2016 Apr 18;11:42. doi: 10.1186/s13023-016-0389-z.

19.

Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis.

Quinlivan A, Thakkar V, Stevens W, Morrisroe K, Prior D, Rabusa C, Youssef P, Gabbay E, Roddy J, Walker JG, Zochling J, Sahhar J, Nash P, Lester S, Rischmueller M, Proudman SM, Nikpour M.

Intern Med J. 2015 Nov;45(11):1134-40. doi: 10.1111/imj.12890.

PMID:
26337683
20.

Weighing the evidence: obesity, metabolic syndrome, and the risk of chronic kidney disease.

Gabbay E, Slotki I, Shavit L.

BMC Nephrol. 2015 Aug 7;16:133. doi: 10.1186/s12882-015-0137-y.

21.

Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease.

Moore OA, Proudman SM, Goh N, Corte TJ, Rouse H, Hennessy O, Morrisroe K, Thakkar V, Sahhar J, Roddy J, Youssef P, Gabbay E, Nash P, Zochling J, Stevens W, Nikpour M.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S111-6. Epub 2015 Aug 5.

PMID:
26243401
22.

Satisfaction with Care of Patients on Hemodialysis.

Richardson MM, Paine SS, Grobert ME, Stidley CA, Gabbay E, Harford AM, Zager PG, Miskulin DC, Meyer KB.

Clin J Am Soc Nephrol. 2015 Aug 7;10(8):1428-34. doi: 10.2215/CJN.11241114. Epub 2015 Jun 30.

23.

Familial pulmonary arterial hypertension at a tertiary referral unit: patterns in presentation and prognosis.

Esmaili A, Jary C, Bulsara M, Fear M, Gabbay E.

Intern Med J. 2015 Mar;45(3):362-3. doi: 10.1111/imj.12695. No abstract available.

PMID:
25735585
24.

A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis.

Hao Y, Thakkar V, Stevens W, Morrisroe K, Prior D, Rabusa C, Youssef P, Gabbay E, Roddy J, Walker J, Zochling J, Sahhar J, Nash P, Lester S, Rischmueller M, Proudman SM, Nikpour M.

Arthritis Res Ther. 2015 Jan 18;17:7. doi: 10.1186/s13075-015-0517-5.

25.

Incentives for caution: the in-center hemodialysis consumer assessment of healthcare providers and systems survey and experience of care.

Gabbay E, Meyer KB.

Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1005-6. doi: 10.2215/CJN.03950414. Epub 2014 May 15. No abstract available.

26.

The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosis.

Morrisroe KB, Stevens W, Nandurkar H, Prior D, Thakkar V, Roddy J, Zochling J, Sahhar J, Tymms K, Sturgess A, Major G, Kermeen F, Hill C, Walker J, Nash P, Gabbay E, Youssef P, Proudman SM, Nikpour M.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-133-7. Epub 2014 Feb 24.

PMID:
24564981
27.

The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study.

Thakkar V, Stevens W, Prior D, Youssef P, Liew D, Gabbay E, Roddy J, Walker JG, Zochling J, Sahhar J, Nash P, Lester S, Rischmueller M, Proudman SM, Nikpour M.

Arthritis Res Ther. 2013;15(6):R193.

28.

Psychometric performance of the CAMPHOR and SF-36 in pulmonary hypertension.

Twiss J, McKenna S, Ganderton L, Jenkins S, Ben-L'amri M, Gain K, Fowler R, Gabbay E.

BMC Pulm Med. 2013 Jul 12;13:45. doi: 10.1186/1471-2466-13-45.

29.

Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated?

Nikpour M, Stevens W, Proudman SM, Buchbinder R, Prior D, Zochling J, Williams T, Gabbay E, Nandurkar H.

Intern Med J. 2013 May;43(5):599-603. doi: 10.1111/imj.12111. Review.

PMID:
23668273
30.

Time from symptoms to definitive diagnosis of idiopathic pulmonary arterial hypertension: The delay study.

Strange G, Gabbay E, Kermeen F, Williams T, Carrington M, Stewart S, Keogh A.

Pulm Circ. 2013 Jan;3(1):89-94. doi: 10.4103/2045-8932.109919.

31.

Dialysis by the book? Treatment of renal failure in a 101-year-old patient.

Gabbay E, Hersch M, Shavit L, Shmuelevitz L, Helviz Y, Shapiro H, Slotki I.

Clin Kidney J. 2013 Feb;6(1):90-92. Epub 2013 Jan 4.

32.

Chronic thromboembolic pulmonary hypertension: treat the patient not the haemodynamics.

Dunne B, van den Broek A, Williams V, Smith G, Revesz T, Edwards M, Gabbay E.

Case Rep Pulmonol. 2012;2012:108672. doi: 10.1155/2012/108672. Epub 2012 Oct 22.

33.

Increase in the proportion of patients hospitalized with acute myocardial infarction with do-not-resuscitate orders already in place between 2001 and 2007: a nonconcurrent prospective study.

Saczynski JS, Gabbay E, McManus DD, McManus R, Gore JM, Gurwitz JH, Lessard D, Goldberg RJ.

Clin Epidemiol. 2012;4:267-74. doi: 10.2147/CLEP.S32034. Epub 2012 Oct 19.

34.

Design and delivery of an e-learning curriculum for physicians involved in the management of pulmonary hypertension.

Dalton B, McNeil K, Keogh A, Williams T, Proudman S, Gabbay E, Kotlyar E, Weintraub R, Kermeen F, Celermajer D, Boland J.

Int J Clin Pract. 2012 Nov;66(11):1117-24. doi: 10.1111/j.1742-1241.2012.02997.x.

PMID:
23067036
35.

Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease.

Moore OA, Goh N, Corte T, Rouse H, Hennessy O, Thakkar V, Byron J, Sahhar J, Roddy J, Gabbay E, Youssef P, Nash P, Zochling J, Proudman SM, Stevens W, Nikpour M.

Rheumatology (Oxford). 2013 Jan;52(1):155-60. doi: 10.1093/rheumatology/kes289. Epub 2012 Oct 13.

PMID:
23065360
36.

Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study.

Ngian GS, Stevens W, Prior D, Gabbay E, Roddy J, Tran A, Minson R, Hill C, Chow K, Sahhar J, Proudman S, Nikpour M.

Arthritis Res Ther. 2012 Oct 5;14(5):R213. doi: 10.1186/ar4051.

37.

Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort.

Strange G, Playford D, Stewart S, Deague JA, Nelson H, Kent A, Gabbay E.

Heart. 2012 Dec;98(24):1805-11. doi: 10.1136/heartjnl-2012-301992. Epub 2012 Jul 3.

38.

Exercise intolerance in pulmonary arterial hypertension.

Fowler RM, Gain KR, Gabbay E.

Pulm Med. 2012;2012:359204. doi: 10.1155/2012/359204. Epub 2012 Jun 10.

39.

Kidney failure treatment: the freedom to choose.

Gabbay E, Meyer KB.

Am J Kidney Dis. 2012 Jul;60(1):5-7. doi: 10.1053/j.ajkd.2012.04.005. No abstract available.

PMID:
22709596
40.

N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.

Thakkar V, Stevens WM, Prior D, Moore OA, Byron J, Liew D, Patterson K, Hissaria P, Roddy J, Zochling J, Sahhar J, Nash P, Tymms K, Celermajer D, Gabbay E, Youssef P, Proudman SM, Nikpour M.

Arthritis Res Ther. 2012 Jun 12;14(3):R143. doi: 10.1186/ar3876.

41.

Prognostic models for older adults.

Gabbay E, Kent DM.

JAMA. 2012 May 9;307(18):1911-2; author reply 1912. doi: 10.1001/jama.2012.3568. No abstract available.

PMID:
22570454
42.

A comparison of the acute haemodynamic response to aerobic and resistance exercise in subjects with exercise-induced pulmonary arterial hypertension.

Fowler RM, Maiorana AJ, Jenkins SC, Gain KR, O'Driscoll G, Gabbay E.

Eur J Prev Cardiol. 2013 Aug;20(4):605-12. doi: 10.1177/2047487312445424. Epub 2012 Apr 13.

PMID:
22505056
43.

Australian perspective regarding recommendations for physical activity and exercise rehabilitation in pulmonary arterial hypertension.

Fowler R, Jenkins S, Maiorana A, Gain K, O'Driscoll G, Gabbay E.

J Multidiscip Healthc. 2011;4:451-62. doi: 10.2147/JMDH.S26617. Epub 2011 Dec 20.

44.

Validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Australian and New Zealand population.

Ganderton L, Jenkins S, McKenna SP, Gain K, Fowler R, Twiss J, Gabbay E.

Respirology. 2011 Nov;16(8):1235-40. doi: 10.1111/j.1440-1843.2011.02030.x.

PMID:
21810146
45.

Effects of high-intensity inspiratory muscle training following a near-fatal gunshot wound.

Hill K, Gain KR, McKay SW, Nathan C, Gabbay E.

Phys Ther. 2011 Sep;91(9):1377-84. doi: 10.2522/ptj.20100241. Epub 2011 Jul 7.

PMID:
21737521
46.

Pharmacoeconomic evidence of bosentan for pulmonary arterial hypertension.

Strange G, Keogh A, Dalton B, Gabbay E.

Expert Rev Pharmacoecon Outcomes Res. 2011 Jun;11(3):253-63. doi: 10.1586/erp.11.26. Review.

PMID:
21671693
47.

Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial.

Ganderton L, Jenkins S, Gain K, Fowler R, Winship P, Lunt D, Gabbay E.

BMC Pulm Med. 2011 May 23;11:25. doi: 10.1186/1471-2466-11-25.

48.

Measurement properties of the 6-min walk test in individuals with exercise-induced pulmonary arterial hypertension.

Fowler RM, Jenkins SC, Maiorana AJ, Gain KR, O'Driscoll G, Gabbay E.

Intern Med J. 2011 Sep;41(9):679-87. doi: 10.1111/j.1445-5994.2011.02501.x.

PMID:
21470356
49.

Survival after the initiation of combination therapy in patients with pulmonary arterial hypertension: an Australian collaborative report.

Keogh A, Strange G, Kotlyar E, Williams T, Kilpatrick D, Macdonald P, Brown K, Pidoux A, Kermeen F, Steele P, Dalton B, Gabbay E.

Intern Med J. 2011 Mar;41(3):235-44. doi: 10.1111/j.1445-5994.2010.02403.x.

PMID:
21118410
50.

Implications of exercise-induced pulmonary arterial hypertension.

Fowler RM, Maiorana AJ, Jenkins SC, Gain KR, O'Driscoll G, Gabbay E.

Med Sci Sports Exerc. 2011 Jun;43(6):983-9. doi: 10.1249/MSS.0b013e318204cdac.

PMID:
21085040

Supplemental Content

Loading ...
Support Center